Measurement of glomerular filtration rate using endogenous d-serine clearance in living kidney transplant donors and recipients

EClinicalMedicine

Shigeaki Nakazawa¹  Ayumu Taniguchi²  Norio Nonomura³  Tomonori Kimura⁴  Yoshitaka Isaka⁵  Toyofumi Abe⁶  Makoto Hirata⁶  Ryoichi Imamura⁶  Ryuichi Sakate⁶  Masataka Kawamura⁶  Atsushi Hesaka⁷  Shiro Takahara⁸  Masaru Horio⁸ 

[1] Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan;Reverse Translational Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan;Department of Nephrology, Kansai Medical Hospital, Osaka, Japan;Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan;Department of Renal Transplantation, Kansai Medical Hospital, Osaka, Japan;Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan;KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan;Laboratory of Rare Disease Resource library, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN);

关键词: d-Serine;    Glomerular filtration rate;    Kidney transplantation;    Creatinine clearance;    d-Serine clearance;   

DOI  :  

来源: DOAJ

【 摘 要 】

Background: Endogenous molecules that provide an unbiased and a precise evaluation of kidney function are still necessary. We explored the potential of clearance of d-serine, a rare enantiomer of serine and a biomarker of kidney function, as a measure of glomerular filtration rate (GFR). Methods: This was a cross-sectional observational study of 200 living kidney transplant donors and recipients enrolled between July 2019 and December 2020 in a single Japanese center, for whom GFR was measured by clearance of inulin (C-in). Clearance of d-serine (C-dSer) was calculated based on blood and urine levels of d-serine, as measured by two-dimensional high-performance liquid chromatography. Analytical performance was assessed by calculating biases. Utilizing data from 129 participants, we developed equations for C-in based on C-dSer and C-cre using a linear regression model, and the performance was validated in 68 participants. Findings: The means of C-in and C-dSer were 66.7 and 55.7 mL/min/1.73 m2 of body surface area, respectively, in the entire cohort. C-dSer underestimated C-in with a proportional bias of 22.0% (95% confidence interval, 14.2–29.8%) and a constant bias of -1.24 (-5.78–3.31), whereas the proportional bias was minor to that of C-cre (34.6% [31.1–38.2%] and 2.47 (-1.18–6.13) for proportional and constant bias, respectively). Combination of C-dSer and C-cre measured C-in with an equation of 0.391 × C-dSer + 0.418 × C-cre + 3.852, which reduced the proportional bias (6.5% [-0.2–13.1%] and -4.30 [-8.87–0.28] for proportional and constant bias, respectively). In the validation dataset, this equation performed well with median absolute residual of 3.5 [2.3–4.8], and high ratio of agreement (ratios of 30% and 15% different from C-in [P30 and P15] of 98.5 [91.4–100] and 89.7 [80.0–95.2], respectively). Interpretation: The smaller proportional bias compared to that of C-cre is an advantage of C-dSer as a measure of C-in. Combinational measurement of d-serine and creatinine, two endogenous molecules, has the potential to serve as a measure of GFR with precision and minor biases and can support important clinical decisions. Funding: Japan Society for the Promotion of Science (JSPS, grant number 17H04188), Japan Agency of Medical Research and Development (AMED, JP20gm5010001), Osaka Kidney Bank (OKF19-0010), Shiseido Co., Ltd and KAGAMI Inc.

【 授权许可】

Unknown